By Michael Susin

Harmony Gold Mining, a leading South African gold mining company, anticipates that its earnings for fiscal year 2023 will surpass the previous year's figures, largely attributed to higher gold prices.

According to a statement released on Wednesday, the company projects earnings per share for the year ending June 30 to fall within the range of 763 to 798 South African cents (equivalent to 43 and 45 U.S. cents). This represents a significant increase compared to the loss per share of 8 U.S. cents reported during the same period last year.

The boost in earnings primarily stems from a surge in revenue due to higher average gold prices. However, the increase in production costs partially offsets this growth.

Harmony Gold Mining also expects headline earnings per share to range between 747 and 850 South African cents, a remarkable increase of 50% to 70% when compared to the previous figure of 499 South African cents.

Furthermore, the company confirms that it has met its production target of 1.4 million to 1.5 million ounces.

Republic First Bancorp Faces Stock De-listing

Analog Devices Shares Sink After Disappointing Guidance

Leave A Reply

Your email address will not be published. Required fields are marked *

Related posts

The U.S. Economy and Prospects for Growth
News

The U.S. Economy and Prospects for Growth

Richmond Federal Reserve President discusses the influence of pandemic-related changes, slowdown in growth due to higher...

Novavax Settlement and Moderna Earnings Boost
News

Novavax Settlement and Moderna Earnings Boost

Novavax's stock surges after settling with Gavi for Covid-19 vaccine agreement and Moderna reports strong earnings, show...

Stitch Fix Reports Narrowed Losses in Q4
News

Stitch Fix Reports Narrowed Losses in Q4

Stitch Fix reports a narrower loss in Q4, although revenue declined and the active customer base decreased. CEO remains...

Grifols' Shares Rise Amidst Progress on Sale of Stake in Shanghai RAAS Blood Products
News

Grifols' Shares Rise Amidst Progress on Sale of Stake in Shanghai RAAS Blood Products

Shares of Grifols increase as the company confirms progress in selling its stake in Shanghai RAAS Blood Products. Finali...